Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Gattaz

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Social Psychiatry and Psychiatric Epidemiology|May 1, 1992
A psychiatric unit in a general hospital in Brazil: predictors of length of stayP Dalgalarrondo, W F Gattaz
Biological Psychiatry|May 1, 1986
Bromocriptine in the treatment of neuroleptic-resistant schizophreniaW F Gattaz, M Köllisch
Acta Psychiatrica Scandinavica|May 1, 1981
Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individualsW F Gattaz, H Beckmann
Journal of Neural Transmission (Vienna, Austria : 1996)|October 27, 2006
Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in ratsE L Schaeffer, W F Gattaz
Journal of Neural Transmission. General Section|January 1, 1993
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesiaW F Gattaz, A Emrich, S Behrens
Psychoneuroendocrinology|January 1, 1985
Increased CSF cortisol levels after neuroleptic treatment in schizophreniaW F Gattaz, D Hannak, H Beckmann
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1982
Glutamate in schizophrenics and healthy controlsW F Gattaz, D Gattaz, H Beckmann
Biological Psychiatry|August 1, 1984
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patientsW F Gattaz, H Cramer, H Beckmann
Arquivos De Neuro-Psiquiatria|September 1, 1988
[Cerebral computed tomography and schizophrenia: a critical review of the literature]C Von Krakauer Hübner, W F Gattaz
Schizophrenia Research|July 1, 1995
Increased platelet phospholipase A2 activity in schizophreniaW F Gattaz, A Schmitt, A Maras
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Social Psychiatry and Psychiatric Epidemiology|May 1, 1992
A psychiatric unit in a general hospital in Brazil: predictors of length of stayP Dalgalarrondo, W F Gattaz
Biological Psychiatry|May 1, 1986
Bromocriptine in the treatment of neuroleptic-resistant schizophreniaW F Gattaz, M Köllisch
Acta Psychiatrica Scandinavica|May 1, 1981
Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individualsW F Gattaz, H Beckmann
Journal of Neural Transmission (Vienna, Austria : 1996)|October 27, 2006
Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in ratsE L Schaeffer, W F Gattaz
Journal of Neural Transmission. General Section|January 1, 1993
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesiaW F Gattaz, A Emrich, S Behrens
Psychoneuroendocrinology|January 1, 1985
Increased CSF cortisol levels after neuroleptic treatment in schizophreniaW F Gattaz, D Hannak, H Beckmann
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1982
Glutamate in schizophrenics and healthy controlsW F Gattaz, D Gattaz, H Beckmann
Biological Psychiatry|August 1, 1984
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patientsW F Gattaz, H Cramer, H Beckmann
Arquivos De Neuro-Psiquiatria|September 1, 1988
[Cerebral computed tomography and schizophrenia: a critical review of the literature]C Von Krakauer Hübner, W F Gattaz
Schizophrenia Research|July 1, 1995
Increased platelet phospholipase A2 activity in schizophreniaW F Gattaz, A Schmitt, A Maras
Pageof 13